In women with BC undergoing trastuzumab therapy, we showed a significant increase in the activity of antioxidant enzymes (SOD, CAT, and GSH-Px) vs. the control group (healthy women), which may be an adaptive response of the body to the intensified production of free radicals. This evidence concerns the gene CAT and breast cancer.